ATE461202T1 - Hiv-integrasehemmer - Google Patents
Hiv-integrasehemmerInfo
- Publication number
- ATE461202T1 ATE461202T1 AT06837651T AT06837651T ATE461202T1 AT E461202 T1 ATE461202 T1 AT E461202T1 AT 06837651 T AT06837651 T AT 06837651T AT 06837651 T AT06837651 T AT 06837651T AT E461202 T1 ATE461202 T1 AT E461202T1
- Authority
- AT
- Austria
- Prior art keywords
- hiv integrase
- integrase inhibitors
- inhibitors
- hiv
- integrase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/20—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73778105P | 2005-11-17 | 2005-11-17 | |
| US11/590,637 US8039458B2 (en) | 2005-11-17 | 2006-10-31 | HIV integrase inhibitors |
| PCT/US2006/044320 WO2007061714A1 (en) | 2005-11-17 | 2006-11-15 | Hiv integrase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE461202T1 true ATE461202T1 (de) | 2010-04-15 |
Family
ID=38041727
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06837651T ATE461202T1 (de) | 2005-11-17 | 2006-11-15 | Hiv-integrasehemmer |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US8039458B2 (de) |
| EP (1) | EP1948666B1 (de) |
| JP (1) | JP2009515981A (de) |
| KR (1) | KR20080069254A (de) |
| CN (1) | CN101360752B (de) |
| AR (1) | AR057896A1 (de) |
| AT (1) | ATE461202T1 (de) |
| AU (1) | AU2006316582B2 (de) |
| CY (1) | CY1110665T1 (de) |
| DE (1) | DE602006013025D1 (de) |
| DK (1) | DK1948666T3 (de) |
| ES (1) | ES2341132T3 (de) |
| HR (1) | HRP20100247T1 (de) |
| NO (1) | NO20081935L (de) |
| PE (1) | PE20071080A1 (de) |
| PL (1) | PL1948666T3 (de) |
| PT (1) | PT1948666E (de) |
| SI (1) | SI1948666T1 (de) |
| TW (1) | TW200738728A (de) |
| WO (1) | WO2007061714A1 (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7763630B2 (en) * | 2007-06-06 | 2010-07-27 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| BRPI0907751A2 (pt) | 2008-02-07 | 2015-07-21 | Bayer Cropscience Ag | Arilpirrolinas inseticidas |
| US8129398B2 (en) * | 2008-03-19 | 2012-03-06 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| WO2010042392A2 (en) * | 2008-10-06 | 2010-04-15 | Merck & Co., Inc. | Hiv integrase inhibitors |
| US8143244B2 (en) | 2009-02-26 | 2012-03-27 | Bristol-Myers Squibb Company | Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors |
| JP2012527414A (ja) | 2009-05-19 | 2012-11-08 | バイエル・クロップサイエンス・アーゲー | 殺虫性アリールピロリン |
| EP2488521B1 (de) * | 2009-10-13 | 2013-12-18 | Elanco Animal Health Ireland Limited | Makrocyclische integraseinhibitoren |
| US8383639B2 (en) * | 2009-10-15 | 2013-02-26 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| US8283366B2 (en) | 2010-01-22 | 2012-10-09 | Ambrilia Biopharma, Inc. | Derivatives of pyridoxine for inhibiting HIV integrase |
| WO2012123449A1 (en) | 2011-03-14 | 2012-09-20 | Boehringer Ingelheim International Gmbh | N- cyclopropyl - n- piperidinylbenzamides as gpr119 modulators |
| EP2718288B1 (de) | 2011-06-09 | 2015-03-11 | Boehringer Ingelheim International GmbH | Substituierte piperidine als gpr119-modulatoren zur behandlung von stoffwechselerkrankungen |
| CA3131037A1 (en) | 2011-11-30 | 2013-06-06 | Emory University | Antiviral jak inhibitors useful in treating or preventing retroviral and other viral infections |
| JP2015523404A (ja) | 2012-08-02 | 2015-08-13 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｎ−シクロプロピル−ｎ−ピペリジニル−アミド、これらを含有する医薬組成物およびその使用 |
| US9714243B2 (en) | 2012-12-17 | 2017-07-25 | Merck Sharp & Dohme Corp. | 4-pyridinonetriazine derivatives as HIV integrase inhibitors |
| EP2986291B1 (de) | 2013-04-16 | 2020-05-27 | Merck Sharp & Dohme Corp. | 4-pyridonderivatverbindungen und verwendungen davon als hiv-integrase-hemmer |
| BR112015026847A2 (pt) | 2013-04-22 | 2017-07-25 | Abbvie Inc | tiazóis e usos dos mesmos |
| LT2997033T (lt) | 2013-05-17 | 2018-02-12 | Merck Sharp & Dohme Corp. | Kondensuoti tricikliniai heterocikliniai junginiai, kaip živ integrazės inhibitoriai |
| WO2014200880A1 (en) | 2013-06-13 | 2014-12-18 | Merck Sharp & Dohme Corp. | Fused tricyclic heterocyclic compounds as hiv integrase inhibitors |
| AP2016009157A0 (en) | 2013-09-27 | 2016-04-30 | Merck Sharp & Dohme | Substituted quinolizine derivatives useful as hiv integrase inhibitors |
| DK3245190T3 (en) * | 2015-01-16 | 2019-02-18 | Bayer Cropscience Ag | METHOD FOR PREPARING 4-CYANOPIPERIDE HYDROCHLORIDE |
| WO2016187788A1 (en) | 2015-05-25 | 2016-12-01 | Merck Sharp & Dohme Corp. | Fused tricyclic heterocyclic compounds useful for treating hiv infection |
| WO2017087257A1 (en) | 2015-11-17 | 2017-05-26 | Merck Sharp & Dohme Corp. | Amido-substituted pyridotriazine derivatives useful as hiv integrase inhibitors |
| WO2017106071A1 (en) | 2015-12-15 | 2017-06-22 | Merck Sharp & Dohme Corp. | Spirocyclic quinolizine derivatives useful as hiv integrase inhibitors |
| WO2017113288A1 (en) | 2015-12-31 | 2017-07-06 | Merck Sharp & Dohme Corp. | Fused tricyclic heterocyclic compounds as hiv integrase inhibitors |
| WO2018010163A1 (zh) * | 2016-07-15 | 2018-01-18 | 泸州东方农化有限公司 | 一种1,2,4-三唑-3-硫酮化合物的合成方法及其中间体 |
| CA3042314A1 (en) | 2016-12-02 | 2018-06-07 | Merck Sharp & Dohme Corp. | Tricyclic heterocycle compounds useful as hiv integrase inhibitors |
| JOP20190130A1 (ar) | 2016-12-02 | 2019-06-02 | Merck Sharp & Dohme | مركبات حلقية غير متجانسة رباعية الحلقات مفيدة كمثبطات إنزيم مدمج لفيروس نقص المناعة البشرية (hiv) |
| WO2018140368A1 (en) | 2017-01-26 | 2018-08-02 | Merck Sharp & Dohme Corp. | Substituted quinolizine derivatives useful as hiv integrase inhibitors |
| CN113795491B (zh) * | 2019-04-30 | 2024-09-03 | 上海拓界生物医药科技有限公司 | 桥环-3,4-二氢-吡啶并[1,2-a]吡嗪-1,8-二酮化合物及其药物用途 |
| CN114426540B (zh) * | 2020-10-29 | 2024-04-26 | 上海拓界生物医药科技有限公司 | 吡啶并[1,2-a]吡嗪-1,8-二酮类前药衍生物、其制备方法及其应用 |
| CN113372335B (zh) * | 2021-07-05 | 2023-02-24 | 山东大学 | 一种含有1,2,4-三唑硫醚的苯丙氨酸衍生物及其制备方法与应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4733986B2 (ja) | 2002-12-27 | 2011-07-27 | イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・ピー・アー | ＨＩＶインテグラーゼ阻害薬として有用なテトラヒドロ−４Ｈ−ピリド［１，２−ａ］ピリミジン類および関連する化合物 |
| AR046938A1 (es) | 2003-12-12 | 2006-01-04 | Merck & Co Inc | Procedimiento para preparar hexahidropirimido[1,2-a]azepin-2-carboxilatos y compuetos similares |
| TW200526635A (en) | 2003-12-22 | 2005-08-16 | Shionogi & Co | Hydroxypyrimidinone derivative having HIV integrase inhibitory activity |
| EP1866313A1 (de) * | 2005-03-31 | 2007-12-19 | Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. | Hiv-integrasehemmer |
| JP4982482B2 (ja) | 2005-05-10 | 2012-07-25 | メルク・シャープ・エンド・ドーム・コーポレイション | Ｈｉｖインテグラ−ゼ阻害剤 |
-
2006
- 2006-10-31 US US11/590,637 patent/US8039458B2/en active Active
- 2006-11-15 DK DK06837651.6T patent/DK1948666T3/da active
- 2006-11-15 PE PE2006001455A patent/PE20071080A1/es not_active Application Discontinuation
- 2006-11-15 PL PL06837651T patent/PL1948666T3/pl unknown
- 2006-11-15 PT PT06837651T patent/PT1948666E/pt unknown
- 2006-11-15 ES ES06837651T patent/ES2341132T3/es active Active
- 2006-11-15 AT AT06837651T patent/ATE461202T1/de active
- 2006-11-15 KR KR1020087014533A patent/KR20080069254A/ko not_active Application Discontinuation
- 2006-11-15 WO PCT/US2006/044320 patent/WO2007061714A1/en active Application Filing
- 2006-11-15 SI SI200630642T patent/SI1948666T1/sl unknown
- 2006-11-15 DE DE602006013025T patent/DE602006013025D1/de active Active
- 2006-11-15 JP JP2008541302A patent/JP2009515981A/ja active Pending
- 2006-11-15 EP EP06837651A patent/EP1948666B1/de active Active
- 2006-11-15 CN CN2006800512376A patent/CN101360752B/zh not_active Expired - Fee Related
- 2006-11-15 AU AU2006316582A patent/AU2006316582B2/en not_active Ceased
- 2006-11-16 AR ARP060105027A patent/AR057896A1/es unknown
- 2006-11-17 TW TW095142505A patent/TW200738728A/zh unknown
-
2008
- 2008-04-23 NO NO20081935A patent/NO20081935L/no not_active Application Discontinuation
-
2010
- 2010-04-29 HR HR20100247T patent/HRP20100247T1/hr unknown
- 2010-06-11 CY CY20101100533T patent/CY1110665T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007061714A1 (en) | 2007-05-31 |
| EP1948666A1 (de) | 2008-07-30 |
| AU2006316582B2 (en) | 2012-01-19 |
| SI1948666T1 (sl) | 2010-06-30 |
| PL1948666T3 (pl) | 2010-08-31 |
| CN101360752A (zh) | 2009-02-04 |
| HRP20100247T1 (hr) | 2010-06-30 |
| US8039458B2 (en) | 2011-10-18 |
| JP2009515981A (ja) | 2009-04-16 |
| CN101360752B (zh) | 2012-09-05 |
| EP1948666B1 (de) | 2010-03-17 |
| ES2341132T3 (es) | 2010-06-15 |
| AU2006316582A1 (en) | 2007-05-31 |
| TW200738728A (en) | 2007-10-16 |
| NO20081935L (no) | 2008-06-24 |
| PE20071080A1 (es) | 2007-11-19 |
| KR20080069254A (ko) | 2008-07-25 |
| US20070111984A1 (en) | 2007-05-17 |
| DE602006013025D1 (de) | 2010-04-29 |
| DK1948666T3 (da) | 2010-05-25 |
| AR057896A1 (es) | 2007-12-26 |
| CY1110665T1 (el) | 2015-06-10 |
| PT1948666E (pt) | 2010-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE461202T1 (de) | Hiv-integrasehemmer | |
| NO20064555L (no) | HIV-integraseinhibitorer. | |
| EP1881825A4 (de) | Hiv-integrasehemmer | |
| EP1725535A4 (de) | Hiv-integrasehemmer | |
| BRPI0910307A2 (pt) | inibidores de hiv integrase | |
| EP1756069A4 (de) | Hiv-integrasehemmer | |
| IL177189A0 (en) | Hiv integrase inhibitors | |
| ATE405570T1 (de) | Hiv-integrase-inhibitoren: cyclische pyrimidinonverbindung | |
| DK1749011T3 (da) | Bicykliske heterocykler som HIV-integrasehæmmere | |
| EP1725102A4 (de) | Hiv-integrasehemmer | |
| DK1934236T3 (da) | Heterobifunktionelle pan-selektininhibitorer | |
| DK1957073T3 (da) | Lægemiddel | |
| DE502006007910D1 (de) | Kran | |
| EP1910363A4 (de) | Hiv-integrasehemmer | |
| EP1756114A4 (de) | Hiv-integrasehemmer | |
| DK1848727T3 (da) | Ibandronat polymorf b | |
| EP1758585A4 (de) | Hiv-integrasehemmer | |
| ATE429417T1 (de) | Hiv-protease-inhibitoren | |
| ATE418545T1 (de) | Nnrt-inhibitoren | |
| DE502006009192D1 (de) | Kran | |
| DK1877549T3 (da) | HIV-vaccine | |
| EP1910356A4 (de) | Hiv-integrasehemmer | |
| EP1909578A4 (de) | Hiv-integrasehemmer | |
| EP1910355A4 (de) | Hiv-integrasehemmer | |
| SE0501944L (sv) | Kranmått |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1948666 Country of ref document: EP |